Arrowhead Research reported $44.15M in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Agios Pharmaceuticals AGIO:US $ -98.67M 3.96M
Alnylam Pharmaceuticals ALNY:US $ -137.27M 45.91M
Anika Therapeutics ANIK:US $ 0.06M 5.22M
Arrowhead Research ARWR:US $ 44.15M 104.9M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Intercept Pharmaceuticals ICPT:US $ -9.9M 10.55M
IONIS PHARMACEUT IONS:US $ -53.21M 278.25M
Ligand Pharmaceuticals LGND:US $ 4.35M 21.55M
Merk MRK:US $ 6179M 492M
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Moderna Inc MRNA:US 4.31B 1.18B
Nektar Therapeutics NKTR:US $ -111.36M 1.88M
Novartis NOVN:VX SF 4552M 346M
Opko Health OPK:US $ -44.61M 0.72M
Sarepta Therapeutics SRPT:US $ -76.16M 19.51M
Spectrum Pharmaceuticals SPPI:US $ -13.99M 22.79M
Tg Therapeutics TGTX:US $ -66.8M 26.07M
Ultragenyx Pharmaceutical RARE:US $ -132.54M 33.51M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M
Xencor XNCR:US $ 28.64M 65.11M
YTE INCY:US $ 144.1M 9.29M